№ files_lp_3_process_7_083931
File format: docx
Character count: 3866
File size: 24 KB
Job description outlining responsibilities, governance requirements, and person specification for a combined medicines management and dispensary business leadership role within a general practice setting.
Location:
Caldbeck Surgery
Hours:
18–21 hours per week
Reports to:
Practice Manager
Type of document:
Job description
Organisation type:
General practice surgery
Role structure:
May be split into two roles depending on the applicant
Main responsibilities:
Medicines management, dispensary business operations, DSQS compliance
Key frameworks referenced:
QOF, QIS, DSQS
Working relationships:
GPs, pharmacists, dispensary team, Practice Manager
Monitoring duties:
Higher-risk medicines register, safety alerts, audits, monthly data collection
Administrative duties:
Monthly medicines-related claims and paperwork
Compliance requirements:
Data protection, Caldicott principles, safeguarding policies
Pre-employment requirements:
Two references, DBS check, qualification verification
Required experience:
Healthcare or general practice experience preferred
Core skills:
Organisational skills, communication skills, IT competence, interest in medicines safety and quality improvement
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
Hamstreet
Theme:
Healthcare, Dispensary Services
Document Type:
Informational Announcement
Organization / Institution:
Hamstreet Dispensary
Author:
Hamstreet Dispensary
Target Audience:
Patients of Hamstreet Dispensary
Effective Period:
From January 2026
Approval Date:
January 2026
Modification Date:
Not specified
Year:
2022
Region / city:
Tullamore, Midland Region
Field:
Healthcare, Pharmacist recruitment
Document type:
Application form
Organization / institution:
Health Service Executive
Author:
Health Service Executive
Target audience:
Job applicants
Period of validity:
Until application deadline
Approval date:
N/A
Date of amendments:
N/A
Contextual description:
Application form for the position of Pharmacist Chief II in the Dispensary Services at Midland Regional Hospital Tullamore, outlining eligibility criteria and application requirements.
Year:
2022
Region / City:
Washington, DC
Topic:
Medical marijuana dispensary application
Document type:
Resolution
Organization / Institution:
Advisory Neighborhood Commission 3C
Author:
Advisory Neighborhood Commission 3C
Target Audience:
District of Columbia residents, local government officials, cannabis industry stakeholders
Effective Period:
2022
Approval Date:
July 18, 2022
Date of Changes:
None
Context:
A resolution supporting Rooted Therapeutics’ application for a medical marijuana dispensary in Ward 3, Washington, D.C.
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Document type:
Q&A guidance
Jurisdiction:
Japan
Subject:
Import and shipment of medicines and medical devices
Issuing authority:
Ministry of Health, Labour and Welfare
Intended users:
Individuals importing or sending medicines for personal use
Scope:
Prescription medicines, injections, syringes, and medical devices
Import purpose:
Personal use
Regulatory framework:
Pharmaceutical and Medical Device regulations
Application system:
Online Import Confirmation system
Related forms:
Import Confirmation Application Form (Form 12); Explanation of Pharmaceutical Product (Form 13)
Year:
2024
Region / city:
Denmark
Topic:
Medicine, Health Economics
Document type:
Template
Organization / institution:
Danish Medicines Council
Author:
Danish Medicines Council
Target audience:
Pharmaceutical companies
Period of validity:
Ongoing
Approval date:
10 September 2024
Date of changes:
1 April 2025
Version:
2.5
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Year:
2020
Region / city:
UK
Theme:
Medicines Information
Document type:
List
Organization / institution:
NHS
Author:
UKMi
Target audience:
NHS Medicines Information Services
Period of validity:
Ongoing, updated quarterly
Approval date:
November 2020
Date of changes:
May 2020
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.
Year:
Not specified
Region / City:
Malaysia
Topic:
Pharmaceutical registration and formulary listing
Document Type:
Application Form
Organization / Institution:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory authorities
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Health, Pharmaceuticals
Document Type:
Informational Resource
Organization / Institution:
U.S. Food and Drug Administration
Target Audience:
Consumers, Healthcare Providers, Information Professionals, Researchers
Year:
2018
Region / City:
Wellington, New Zealand
Topic:
Medicine administration
Document type:
Guideline
Organization / Institution:
New Zealand Nurses Organisation
Author:
New Zealand Nurses Organisation
Target audience:
Nurses, midwives
Period of validity:
Not specified
Approval date:
2018
Date of changes:
Not specified
ISBN:
978-1-877461-66-8
Year:
2025
Location:
Glen Ellyn, Illinois, USA
Document Type:
Invitation to Bid
Issuing Organization:
Village of Glen Ellyn
Contact Person:
Nick Burgoni, Utilities Superintendent
Submission Deadline:
February 21, 2025, 10:00 AM
Pre-bid Conference:
February 14, 2025, 9:00 AM
Bid Security Requirement:
Cashier’s or Certified Check, or Bid Bond (5% of total contract price)
Applicable Law:
Illinois Prevailing Wage Act, 820 ILCS 130/0.01 et seq.
Contract Type:
Independent Contractor Agreement
Public Opening:
February 21, 2025, 10:00 AM
Year:
2026
Region / City:
Glasgow, Scotland
Theme:
Clinical governance, quality improvement, healthcare services
Document type:
Job description
Organization:
NHS Greater Glasgow & Clyde
Author:
NHS Greater Glasgow & Clyde
Target audience:
Healthcare professionals, management teams
Period of activity:
Ongoing
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
Detailed job description for the Lead Clinical Improvement Coordinator role within the Clinical Governance Support Unit (CGSU) at NHS Greater Glasgow & Clyde, focusing on quality improvement and patient safety.